Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 3
2008 4
2009 3
2010 2
2011 1
2012 4
2013 5
2014 4
2015 5
2016 10
2017 16
2018 12
2019 3
2020 8
2021 7
2022 9
2023 7
2024 6
2025 11
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean moulis c[Author] (89 results)?
LRRK2-targeting antisense oligonucleotide in Parkinson's disease: a phase 1 randomized controlled trial.
Mabrouk OS, Tichler B, Arnold HM, Thoma EC, Alexanian SM, Chen J, Liu TY, Hirschhorn B, Llorens Arenas R, Annand JW, Kapadnis U, Shomo AA, Glajch KE, Ferber K, Moroishi Y, Czerkowicz J, Inra J, Postuma RB, Gurevich T, Mir P, Morris HR, Aldred J, Brodsky MA, Ellenbogen A, Larson D, Tolleson CM, Siderowf A, Tzoulis C, Balaguer E, Marti MJ, Zhao HT, Kordasiewicz HB, Lane R, Hirst WD, Fradette S, Graham DL. Mabrouk OS, et al. Among authors: tzoulis c. Nat Med. 2026 Mar 24. doi: 10.1038/s41591-026-04262-4. Online ahead of print. Nat Med. 2026. PMID: 41876647
The NAD-brain pharmacokinetic study of NAD augmentation in blood and brain using oral precursor supplementation.
Berven H, Svensen M, Eikeland H, Tvedten N, Sheard EV, Af Geijerstam SA, Søgnen M, McCann A, Arnsten L, Årseth O, Skjeie V, Hjellbrekke A, Skeie GO, Torres Cleuren YN, Nido GS, Haugarvoll K, Riemer F, Tzoulis C, Dölle C. Berven H, et al. Among authors: tzoulis c. iScience. 2026 Jan 27;29(3):114764. doi: 10.1016/j.isci.2026.114764. eCollection 2026 Mar 20. iScience. 2026. PMID: 41858901 Free PMC article.
Emerging strategies, applications and challenges of targeting NAD+ in the clinic.
Zhang J, Wang HL, Lautrup S, Nilsen HL, Treebak JT, Watne LO, Selbæk G, Wu LE, Omland T, Pirinen E, Cheung TC, Wang J, Ziegler M, Tysnes OB, Zapata-Pérez R, Bruzzone S, Canto C, Deleidi M, Janssens GE, Houtkooper RH, Scheibye-Knudsen M, Koshizaka M, Yokote K, Verdin E, Bohr VA, Tzoulis C, Sinclair DA, Fang EF. Zhang J, et al. Among authors: tzoulis c. Nat Aging. 2025 Sep;5(9):1704-1731. doi: 10.1038/s43587-025-00947-6. Epub 2025 Sep 9. Nat Aging. 2025. PMID: 40926126 Review.
Platelet mitochondrial complex I and IV activities are not reliable stratification biomarkers in Parkinson's disease.
Kverneng SU, Mostafavi S, Mikhaleva Y, Johanson GAS, Berven H, Lundervold K, Skeie GO, Sheard E, Søgnen M, Geijerstam SA, Vetås T, Brischigliaro M, Fernandez-Vizarra E, Torres Cleuren YN, Dölle C, Tzoulis C. Kverneng SU, et al. Among authors: tzoulis c. J Parkinsons Dis. 2025 Nov;15(7):1218-1228. doi: 10.1177/1877718X251365253. Epub 2025 Aug 14. J Parkinsons Dis. 2025. PMID: 40808415 Free article.
114 results